Put companies on watchlist
Katjes International GmbH & Co. KG
ISIN: NO0012888769
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Katjes International GmbH & Co. KG · ISIN: NO0012888769 · EQS - Company News (2 News)
Country: Germany · Primary market: Norway · EQS NID: 1868835
27 March 2024 12:00PM

Katjes International growing by 28.1%


EQS-News: Katjes International GmbH & Co. KG / Key word(s): Annual Report/Annual Results
Katjes International growing by 28.1%

27.03.2024 / 12:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


 Katjes International growing by 28.1%

  • Group sales increase to EUR 377.4 million (previous year: EUR 294.5 million)
  • Group operating result (EBITDA) at EUR 40.8 million (previous year: EUR 37.3 million)
  • Sales and EBITDA margin therefore above the guidance

Emmerich, 27. March 2024 – Katjes International concluded the financial year 2023 very successfully in a continuously challenging market environment and exceeded the guidance which had already been raised over the course of the year. The consolidated financial statements for the corresponding reporting period, prepared in accordance with international accounting standards (IFRS), were published today.

Consolidated sales increased by 28.1% from EUR 294.5 million to EUR 377.4 million in the financial year 2023 and were therefore above the guidance of EUR 350-375 million, which had already been raised following the publication of the interim consolidated financial statements in 2023. The consolidated operating result (EBITDA) amounted to EUR 40.8 million (previous year: EUR 37.3 million). The key performance indicator for Katjes International is the EBITDA margin. In the reporting period, this was 10.8% (previous year: 12.7%) and therefore also above the guidance of 9-10%.

Group equity increased to EUR 176.0 million as of the balance sheet date of December 31, 2023, while the equity ratio remained stable at a comfortable level of 36.9%.

In September 2023, the outstanding EUR 110 million bond from 2019 was refinanced early and the volume of the newly issued bond in September 2023 was increased by EUR 5 million to a total of EUR 115 million due to high demand. There was a good response to the exchange offer granted to existing investors for the first time, as well as the first time possibility of subscription via the issuer's website. In addition, demand from institutional investors as part of the international private placement was also very strong. Therefore, the Katjes International management draws – similar to the three previous bond placements - a very positive conclusion of the 2023/2028 bond, which was issued for the first time structured as a so-called “Nordic Bond”.

Building on the strong brand portfolio and the goal of achieving further growth both through acquisitions and organically, the company is optimistic about the future. The guidance for the current financial year comprises Group sales of between EUR 390 million and EUR 420 million and an EBITDA margin of between 9% and 10%.

The audited consolidated financial statements for 2023 are available at https://katjes-international.de/en/investors/ .

       

CONTACT
Katjes International GmbH & Co. KG
Tel.: +49 (0) 2822/601-700
Fax: +49 (0) 2822/601-125
E-Mail: kontakt@katjes-international.de
Website: www.katjes-international.de/en/

 

ABOUT KATJES INTERNATIONAL

Katjes International GmbH & Co. KG, together with its two legally independent sister companies, the well-known confectionery manufacturer Katjes Fassin GmbH & Co. KG and Katjesgreenfood GmbH & Co. KG, as well as the respective subsidiaries and investments of these three companies, form the Katjes Group ("Katjes Group"). With a focus on so-called Fast Moving Consumer Goods - FMCG (mainly confectionery and personal care products) in Europe, the issuer bundles its investments in companies with (from the point of view of the Katjes Group) strong and established brands. In doing so, the issuer sees itself as a carve-out investor, such as in the acquisitions of Galderma/Nestlé and the latest transaction with Henkel. The business includes the seven subsidiaries Sperlari with Dulcioliva and Paluani in Italy, the German companies Piasten, Dallmann's Pharma Candy with Bübchen and the Oral Care division, and Harlekijntjes in the Netherlands. In addition, the company holds interests of over 55% in the British company

Candy Kittens Limited and of around 23% in the French company Carambar & Co. (CPK).

For more information, visit https://katjes-international.de/en/

 

INFORMATION AND EXPLANATIONS OF THE ISSUER CONCERING THIS ANNOUNCEMENT

To the extent that this release contains forward-looking statements, these statements are based on plans, estimates and projections currently available to Katjes International. Forward-looking statements therefore speak only as of the date they are made. Katjes International assumes no obligation to update or develop such statements in light of new information or future events. By their nature, forward-looking statements involve risks and uncertainties. A variety of important factors could cause actual results to differ materially from those in forward-looking statements.

-----------------------------------

IMPORTANT NOTE

This announcement constitutes neither an offer to sell nor a solicitation to buy or subscribe for securities of Katjes International GmbH & Co KG. This communication does not constitute an offer of securities for sale in the United States of America. Securities may not be offered or sold in the United States of America absent registration under the U.S. Securities Act of 1933 or an exemption from its registration requirements. The securities have not been and will not be registered. Katjes International GmbH & Co. KG does not intend to conduct a public offering of securities in the United States of America. No exchange offer is being made in the United States of America with respect to any securities described in this announcement. Any purported exchange order submitted by a person located in the United States of America or by an agent or other intermediary acting for such person on a non-discretionary basis is void and will be rejected.

This publication is not an offer of securities for sale in Canada, Japan or Australia



27.03.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Katjes International GmbH & Co. KG
Dechant-Sprünken-Str. 53-57
46446 Emmerich am Rhein
Germany
Phone: +49 (0)2822 601 700
Fax: +49 (0)2822 601 125
E-mail: kontakt@katjes-international.de
Internet: www.katjes-international.de
ISIN: NO0012888769
WKN: A30V78
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1868835

 
End of News EQS News Service

1868835  27.03.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1868835&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.